Warren Ong
Psychiatry · Warwick, RINPI 1003896101
Payments from drug & device makers
Across 846 payments — averaging $953.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$320K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$196K
- Otsuka America Pharmaceutical, Inc.$129K
- E.r. Squibb & Sons, L.L.C.$93K
- Teva Pharmaceuticals USA, Inc.$60K
- Sunovion Pharmaceuticals Inc.$7K
- plus $2K from 7 others
What the payments were for
- Consulting fees$49,3516%
- Speaking & faculty fees$674,66084%
- Travel & lodging$57,8057%
- Food & beverage$24,9813%
- Education$670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 325 | $320,023 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 185 | $195,537 |
| Otsuka America Pharmaceutical, Inc. | 137 | $129,093 |
| E.r. Squibb & Sons, L.L.C. | 99 | $92,608 |
| Teva Pharmaceuticals USA, Inc. | 77 | $60,167 |
| Sunovion Pharmaceuticals Inc. | 7 | $7,194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $1,906 |
| AbbVie | 5 | $135 |
| Alkermes, Inc. | 4 | $106 |
| Lundbeck LLC | 2 | $37 |
| Braeburn Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$313,925
- CAPLYTA$192,851
- ABILIFY MAINTENA$119,572
- COBENFY$72,972
- AUSTEDO$43,090
- ABILIFY ASIMTUFII$24,795
- Austedo XR$15,908
- ABILIFY MYCITE$7,241
- LATUDA$7,104
- TRINTELLIX$1,906
How this compares
$806,863 in reported general payments places this provider in the 95th percentile of 209 psychiatry providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 24 | $148,164 |
| IngrezzaValbenazine Tosylate | 16 | $143,330 |
| CaplytaLumateperone Tosylate | 67 | $113,246 |
| RexultiBrexpiprazole | 48 | $66,833 |
| Abilify AsimtufiiAripiprazole | 13 | $60,269 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 218 | $8,402 |
| Lurasidone Hcl | 62 | $4,716 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,439 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 40 | $3,578 |
| Clonazepam | 202 | $3,241 |
| Alprazolam | 143 | $1,907 |
| Quetiapine Fumarate | 78 | $1,640 |
| Aripiprazole | 33 | $1,629 |
| Bupropion XlBupropion Hcl | 92 | $1,575 |
| Lorazepam | 109 | $1,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $60,167 | $148,16424 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $320,023 | $143,33016 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Asimtufii | $129,093 | $127,10361 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $195,537 | $113,24667 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $1,906 | $4,43912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 209 psychiatry providers in Rhode Island.
Other psychiatry in Warwick
- Liliya KoyfmanWarwick$110K
- Terrie MailhotWarwick$26K
- Ethan KischWarwick$24K
- James GalloWarwick$4K
- David KroesslerWarwick$3K
- Charles DenbyWarwick$2K
- Sandhya PatelWarwick$2K
- Alexander ScagnelliWarwick$983
- Richard WhalenWarwick$661
- Rafael TorresWarwick$476
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.